Staphylococcus aureus : place et impact dans la prise en charge des pneumopathies nosocomiales

In addition to the antibiotics classically active against SA (notably methicillin for sensitive strains and glycopeptides for MRSA) new agents may allow improvement in the treatment of these patients, even if their place is not yet definitively established.